Overexpression of EGFR occurs in ~60% of NSCLC patients and is associated with poor differentiation, increased tumor proliferation, higher incidence of metastases, and lower efficacy (30, 31). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.